WTWerner W. A. Tabak

Werner W. A. Tabak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Werner W. A. Tabak has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Photocaged N‐Phosphonopiperidinone as a Selective Photo‐Cleavable DPP8/9 Inhibitor

    by Leonard Sewald, Niko Molke, Werner W. A. Tabak, Anette Haak, Maja Najdzion, Ruth Geiss‐Friedlander, Doris Hellerschmied, Robert Huber, Markus Kaiser

    The strategic introduction of photocages into chemical probes represents a powerful approach to generate spatiotemporally controlled tools with promising applications in chemical biology and drug discovery. This approach is particularly useful for inhibitors of proteins with cell‐type‐dependent functions, as they enable, via light‐triggered selection, the study of their function in selected cells within multicellular organisms. The intracellular dipeptidyl peptidases 8 and 9 (DPP8/9) are serine hydrolases that act in a cell type‐dependent fashion, in diverse biological processes such as inflammation and tumorigenesis. So far, no photocaged inhibitors for DPP8/9 are available, thus hampering their systematic investigations in biomedical research model systems such as mice. Herein, the development of a green light‐cleavable, BODIPY‐photocaged N‐phosphono‐piperidone‐based DPP8/9 inhibitor is presented. This covalent‐acting inhibitor is characterized by its photolysis properties, including a demonstration of its low phototoxicity, as well as potency and selectivity, in biochemical, biological, and, as an extension to these traditional validation approaches, chemical proteomics assays. These studies not only reveal the suitability of the developed photocages for cellular applications, as a prerequisite for their application in multicellular organisms, but also highlight the benefit of chemical proteomics workflows such as activity‐based protein profiling for characterizing proteome‐wide potencies and selectivities of photocaged compounds.


  • Bacterial pathogen deploys the iminosugar glycosyrin to manipulate plant glycobiology

    by Nattapong Sanguankiattichai, Balakumaran Chandrasekar, Yuewen Sheng, Nathan Hardenbrook, Werner W. A. Tabak, Margit Drapal, Farnusch Kaschani, Clemens Grünwald-Gruber, Daniel Krahn, Pierre Buscaill, et al.

    The extracellular space (apoplast) in plants is a key battleground during microbial infections. To avoid recognition, the bacterial model phytopathogen Pseudomonas syringae pv. tomato DC3000 produces glycosyrin. Glycosyrin inhibits the plant-secreted β-galactosidase BGAL1, which would otherwise initiate the release of immunogenic peptides from bacterial flagellin. Here, we report the structure, biosynthesis, and multifunctional roles of glycosyrin. High-resolution cryo–electron microscopy and chemical synthesis revealed that glycosyrin is an iminosugar with a five-membered pyrrolidine ring and a hydrated aldehyde that mimics monosaccharides. Glycosyrin biosynthesis was controlled by virulence regulators, and its production is common in bacteria and prevents flagellin recognition and alters the extracellular glycoproteome and metabolome of infected plants. These findings highlight a potentially wider role for glycobiology manipulation by plant pathogens across the plant kingdom.


  • Open Access

    Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitors

    by Leonard Sewald, Werner W. A. Tabak, Lorenz Fehr, Samuel Zolg, Maja Najdzion, Carlo J. A. Verhoef, David Podlesainski, Ruth Geiss-Friedlander, Alfred Lammens, Farnusch Kaschani, et al.

    Covalent chemical probes and drugs combine unique pharmacologic properties with the availability of straightforward compound profiling technologies via chemoproteomic platforms. These advantages have fostered the development of suitable electrophilic “warheads” for systematic covalent chemical probe discovery. Despite undisputable advances in the last years, the targeted development of proteome-wide selective covalent probes remains a challenge for dipeptidyl peptidase (DPP) 8 and 9 (DPP8/9), intracellular serine hydrolases of the pharmacologically relevant dipeptidyl peptidase 4 activity/structure homologues (DASH) family. Here, we show the exploration of the natural product Sulphostin, a DPP4 inhibitor, as a starting point for DPP8/9 inhibitor development. The generation of Sulphostin-inspired N-phosphonopiperidones leads to derivatives with improved DPP8/9 inhibitory potency, an enhanced proteome-wide selectivity and confirmed DPP8/9 engagement in cells, thereby representing that structural fine-tuning of the warhead’s leaving group may represent a straightforward strategy for achieving target selectivity in exoproteases such as DPPs.


  • Open Access

    Bacterial pathogen deploys iminosugar galactosyrin to manipulate plant glycobiology

    by Nattapong Sanguankiattichai, Balakumaran Chandrasekar, Yuewen Sheng, Nathan Hardenbrook, Werner W. A. Tabak, Daniel Krahn, Margit Drapal, Pierre Buscaill, Suzuka Yamamoto, Atsushi Kato, et al.

    The extracellular space (apoplast) of plants is an important molecular battleground during infection by many pathogens. We previously found that a plant-secreted β-galactosidase BGAL1 acts in immunity by facilitating the release of immunogenic peptides from bacterial flagellin and that Pseudomonas syringae suppresses this enzyme by producing a small molecule inhibitor called galactosyrin. Here, we elucidated the structure and biosynthesis of galactosyrin and uncovered its multifunctional roles during infection. Structural elucidation by cryo-EM and chemical synthesis revealed that galactosyrin is an iminosugar featuring a unique geminal diol attached to the pyrrolidine moiety that mimics galactose binding to the β-galactosidase active site. Galactosyrin biosynthesis branches off from purine biosynthesis and involves three enzymes of which the first is a reductase that is unique in iminosugar biosynthesis. Besides inhibiting BGAL1 to avoid detection, galactosyrin also changes the glycoproteome and metabolome of the apoplast. The manipulation of host glycobiology may be common to plant-associated bacteria that carry putative iminosugar biosynthesis clusters.